Clinical Trial Update: A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes [NA]

View source ↗

Summary

The randomized trial evaluating the Control-IQ+ automated insulin delivery system in adults with type 2 diabetes treated with insulin has completed enrollment a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Control-IQ Technology

Snippet

Sponsor: Tandem Diabetes Care, Inc. | Conditions: Type 2 Diabetes Treated With Insulin | NA | Status: COMPLETED | Results posted: 2025-06-03